Related Experiment Video
Updated: Jan 15, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
The prevalence of and risk factors for bronchiectasis in inflammatory bowel disease: a chest CT-based case-control
Jiaqi Ren1, Lina Sun1, Meijiao Li2
1Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Research Center for Chronic Airway Diseases, Peking University Health Science Center, Beijing, China.
Background:
To identify the prevalence, clinical and imaging characteristics, and the risk factors for bronchiectasis in IBD.
Research Design And Methods:
We retrospectively enrolled IBD patients from 1 January 2020 to 1 July 2022. Chest HRCT was evaluated for the presence and severity of bronchiectasis. The clinical characteristics were compared between the IBD patients with and without bronchiectasis.
Results:
Among the 429 IBD patients, 34.5% showed bronchiectasis on chest HRCT. Four main imaging characteristics of bronchiectasis showed in IBD patients: multiple lobe involvement: 72.3% (107/148) of the patients had ≥2 lobes involved; Central predominance (>50%) in distribution; Mostly cylindrical bronchiectasis (>90%); Mild severity in most cases with Smith score <4 and Bhalla score of one point. Multi-factor logistic regression analysis showed that age of IBD onset ≥35 years (OR = 2.05, 95%CI 1.26-3.32), history of immunosuppressant therapy (OR = 3.93, 95%CI 2.12-7.27), ESR > 20 mm/h (OR = 2.01, 95%CI 1.21-3.33) and positive ASCA (OR = 1.37, 95% CI 1.06-1.77) were independently associated with the presence of bronchiectasis in IBD.
Conclusions:
More than 1/3 IBD patients in our cohort presented bronchiectasis on chest HRCT, with almost no respiratory symptoms and the mild degree of bronchiectasis, which is easily overlooked. IBD patients may need routine chest HRCT scanning for bronchiectasis.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

